Search

everythinglearnresearchcommunity

for

Search:↓

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Cetuximab can cause unusual hair growth and hair loss.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

EGFR helps control how hair grows and forms without needing p53 protein.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Cetuximab can cause eyelash growth, which is rare but manageable.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

GLI1 might protect against the start of skin cancer and is not linked to cancer severity.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.